DOCSLIB.ORG

The Dorsal Column Lesion Model and Quantification of Regeneration of the Injured Ascending Sensory Afferents After Experimental Intervention

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
The Dorsal Column Lesion Model and Quantification of Regeneration of the Injured Ascending Sensory Afferents After Experimental Intervention The dorsal column lesion model and quantification of regeneration of the injured ascending sensory afferents after experimental intervention by Mike van Zwieten (10159029) A thesis submitted for the degree of Master of Science in Brain and Cognitive Sciences Track: Behavioural Neuroscience In collaboration with Callan L. Attwell, MSc, Dr. Matthew R. J. Mason and Prof. dr. Joost Verhaagen Netherlands Institute for Neuroscience, Neuroregeneration Labarotory Co-assessor: Prof. dr. Paul J. Lucassen Swammerdam Institute for Life Sciences, University of Amsterdam Acknowledgements I would like to express my deepest gratitude to Callan Attwell, with whom I have worked with for the past 4 months. His continuous guidance has greatly transformed my way of approaching research questions, conceptional knowledge and writing scientific reports. Callan always found time to discuss with me about my questions and ideas in detail. I cannot thank him enough for his supervision, encouragement and support. I also want to thank prof. dr. Joost Verhaagen for his hospitality of taking me up in the Neuroregeneration group at the Netherlands Institute for Neuroscience and, together with dr. Matthew Mason, for the guidance, feedback and input in my project during the discussions in our weekly meetings. 2 Abstract Trauma to the spinal cord usually leads to permanent loss or severe impairment of motor, sensory and autonomic function. The lack of a pro-regenerative response in the central nervous system partially determines the irreversible structural and functional impairments following injury of the spinal cord. Experimental models for spinal cord injury, such as the dorsal column lesion model, allow the study of axon regeneration upon therapeutic interventions to promote axonal outgrowth and plasticity in injured sensory dorsal root ganglion neurons. The dorsal root ganglion neurons bifurcate into two branches, one going into the periphery and the other going into the spinal cord. Specifically, the dorsal column lesion model is characterized by its uniqueness in terms of this anatomical feature of dorsal root ganglion neurons, since the regenerative capacity of both branches fundamentally differ. The peripheral branch of the dorsal root ganglion neuron, as seen in the sciatic nerve, exhibit greater regenerative abilities compared to the central branch, which carries sensory information into the spinal cord via the dorsal columns. Altogether, the dorsal column lesion model provides an excellent model to study genetic and molecular factors underlying processes which regulate neuroregeneration. In this thesis, I will discuss the dorsal column lesion model and the variation in previous research on the level of surgical procedures, histology and functional testing. In addition, I will also elaborate on the applicability of experimental interventions in the dorsal column lesion model to promote axon regeneration and functional recovery after spinal cord injury. Glossary AAV = adeno-associated virus DRG = dorsal root ganglion Arg1 = arginase 1 GAP43 = growth associated protein 43 ATF3 = activating transcription factor 3 GCaMP = GFP calmodulin peptide BDA = biotinylated dextran amide GFAP = glial fibrillary acidic protein BDNF = brain derived neurotrophic factor GFP = green fluorescent protein B-HRP = choleragenoid horseradish peroxidase HDAC = histone deacetylase BMP = bone morphogenic protein HRP = horseradish peroxidase BMSC = bone marrow stromal cell IL-6 = interleukin 6 cAMP = cyclic adenosine monophosphate MAG = myelin-associated glycoprotein CAP23 = brain abundant membrane attached signal protein 1 OEC = olfactory ensheathing cell ChABC = chondroitinase ABC PCAF = p300/CBP-associated factor c-jun = transcription factor AP-1 PKC = protein kinase C, CL = conditioning lesion PNS = peripheral nervous system CNS = central nervous system RAG = regeneration associated gene CREB = cAMP responsive element binding protein SCI = spinal cord injury CST = corticospinal tract SLPI = secretory leukocyte protease inhibitor CTB = cholera toxin b subunit Smad1 = mothers against decapentaplegic homolog 1 dbcAMP = dibutyryl cAMP, SN = sciatic nerve DC = dorsal column STAT3 = signal transducer and activator of transcription 3 DexTR = Texas red-conjugated dextran TF = transcription factor DREZ = dorsal root entry zone YFP = yellow fluorescent protein 3 Table of contents 1 Introduction . 5 1.1 The dorsal column lesion model . 5 1.2 Thesis overview . 6 2 Experimental model for dorsal column injury . 7 2.1 Transection injury models . 7 2.2 Contusion injury models . 9 2.3 Crush injury models . 9 3 Assessment of regeneration and functional recovery . 11 3.1 Histological quantification of axon regeneration . 11 3.2 Functional analysis of regeneration . 12 4 Experimental intervention strategies to promote axon plasticity and regeneration . 14 4.1 The conditioning lesion effect and the RAG program . 14 4.2 Retrograde signaling after injury . 15 4.3 Initiation of pro-regenerative gene expression . 16 4.4 Studies on the RAG program in injured DRG neurons . 16 4.5 Regeneration-associated transcription factors . 16 4.6 Neuron-extrinsic experimental interventions . 18 5 Conclusion . 32 4 Chapter 1 Introduction Spinal cord injury (SCI) usually leads to permanent loss or severe impairment of motor, sensory and autonomic function. Although patients show some spontaneous recovery after injury, most of the patients with significant spinal cord damage are afflicted with a significant physical, emotional, social and economic burden (NSCISC 2013). Published reports showed that the annual SCI incidence rate in the US is on average 40 per million and in Europe varying from 12.1 per million in the Netherlands and 57.8 per million in Portugal (Devivo, 2012; van den Berg et al., 2010). So far management of SCI is challenging and there has been no treatment for it. This provides support for the notion that it is important to explore effective treatments for SCI patients. Most spinal cord lesions are incomplete, and in many cases, the clinical deficits reflect the extent of the injury. Depending on the nature and the severity of the injury, a spinal cord lesion could directly damage spinal axons of ascending and descending fiber tracts. Damage to these connections leaves spinal segments caudal to the lesion site partially or totally isolated from the brain (Bradbury and McMahon, 2006). The distal segment of the injured axon is retracted from the postsynaptic neuron and eliminated by degeneration (Wang et al., 2012a). The neuron together with the proximal axon segment, which usually retract a certain distance from the lesion site, typically survives, but must regenerate and reconnect to its target neurons to restore sensory function (Bradbury and McMahon, 2006). 1.1 The dorsal column lesion model Animal models are used to help predict the functional outcomes of neurological disorders and injuries and to test the efficacy of therapeutic interventions. SCI has been studied using several different animal models, including transient compression and contusion injury, complete and partial transections, crush injury and transections of specific spinal cord tracts (Figure 1 and 2). In this thesis, I focus on the technical variability in injury models of the ascending sensory neurons in the dorsal columns (DC) of the spinal cord. The DC lesion paradigm is an useful model to study axon regeneration and/or functional recovery of ascending sensory afferents following injury of the spinal cord. Sensory information that is carried in the DC arises from the periphery via dorsal root ganglion (DRG) cells. DRG neurons, often called primary sensory neurons, are pseudo-unipolar cells with a peripheral branch, such as found in the sciatic nerve (SN), and a central branch in the spinal cord, both departing from a single cell body in the DRG (Figure 3). The peripheral branch innervates peripheral targets and receives somatic information such as discriminatory touch, vibration, position sense, movement sense, conscious proprioception and tactile information (Sengul and Watson, 2014), and connect to the spinal cord via the dorsal roots. Besides that, axons in the peripheral nervous system (PNS) also derive from the autonomic nervous system for involuntary control of visceral functions (Sengul and Watson, 2014). The central branch of the DRG neurons carries this sensory information into the central nervous system (CNS) by entering the spinal cord via the dorsal root entry zone (DREZ) and ascending via the DC to subsequently connect to second-order neurons in nuclei located along the spinal cord and brain stem which project to higher centers in the brain (Figure 3). The peripheral and the central branch of DRG neurons differ fundamentally in their response to injury, even though they originate from the same cell body. The peripheral branches of DRG neurons show some degree of spontaneous regeneration after injury, whereas the central branches display very limited regeneration in response to a lesion of the dorsal roots and roughly no regeneration upon injury of the DC. The fact that central branches of DRG 5 neurons show limited spontaneous regeneration is likely due to neuron-extrinsic and neuron-intrinsic factors. After injury of the peripheral branch of the DRG neurons, a neuron-intrinsic response is initiated where expression of genes is altered towards a more pro-regenerative state, usually referred to as the regeneration-associated gene (RAG) program (Tetzlaff et al., 1991; Skene, 1989). DC axons, i.e. central branches
Load more

Recommended publications
  • The Creation of Neuroscience
    The Creation of Neuroscience The Society for Neuroscience and the Quest for Disciplinary Unity 1969-1995 Introduction rom the molecular biology of a single neuron to the breathtakingly complex circuitry of the entire human nervous system, our understanding of the brain and how it works has undergone radical F changes over the past century. These advances have brought us tantalizingly closer to genu- inely mechanistic and scientifically rigorous explanations of how the brain’s roughly 100 billion neurons, interacting through trillions of synaptic connections, function both as single units and as larger ensem- bles. The professional field of neuroscience, in keeping pace with these important scientific develop- ments, has dramatically reshaped the organization of biological sciences across the globe over the last 50 years. Much like physics during its dominant era in the 1950s and 1960s, neuroscience has become the leading scientific discipline with regard to funding, numbers of scientists, and numbers of trainees. Furthermore, neuroscience as fact, explanation, and myth has just as dramatically redrawn our cultural landscape and redefined how Western popular culture understands who we are as individuals. In the 1950s, especially in the United States, Freud and his successors stood at the center of all cultural expla- nations for psychological suffering. In the new millennium, we perceive such suffering as erupting no longer from a repressed unconscious but, instead, from a pathophysiology rooted in and caused by brain abnormalities and dysfunctions. Indeed, the normal as well as the pathological have become thoroughly neurobiological in the last several decades. In the process, entirely new vistas have opened up in fields ranging from neuroeconomics and neurophilosophy to consumer products, as exemplified by an entire line of soft drinks advertised as offering “neuro” benefits.
    [Show full text]
  • Pain Improvement in Parkinson's Disease Patients Treated
    Journal of Personalized Medicine Article Pain Improvement in Parkinson’s Disease Patients Treated with Safinamide: Results from the SAFINONMOTOR Study Diego Santos García 1,* , Rosa Yáñez Baña 2, Carmen Labandeira Guerra 3, Maria Icíar Cimas Hernando 4, Iria Cabo López 5 , Jose Manuel Paz González 1, Maria Gema Alonso Losada 3, Maria José Gonzalez Palmás 5, Carlos Cores Bartolomé 1 and Cristina Martínez Miró 1 1 Department of Neurology, CHUAC, Complejo Hospitalario Universitario de A Coruña, 15006 A Coruña, Spain; [email protected] (J.M.P.G.); [email protected] (C.C.B.); [email protected] (C.M.M.) 2 Department of Neurology, CHUO, Complejo Hospitalario Universitario de Ourense, 32005 Ourense, Spain; [email protected] 3 Department of Neurology, CHUVI, Complejo Hospitalario Universitario de Vigo, 36213 Vigo, Spain; [email protected] (C.L.G.); [email protected] (M.G.A.L.) 4 Hospital de Povisa, 36211 Vigo, Spain; [email protected] 5 Department of Neurology, CHOP, Complejo Hospitalario Universitario de Pontevedra, 36002 Pontevedra, Spain; [email protected] (I.C.L.); [email protected] (M.J.G.P.) * Correspondence: [email protected]; Tel.: +34-646-173-341 Citation: Santos García, D.; Yáñez Abstract: Background and objective: Pain is a frequent and disabling symptom in Parkinson’s disease Baña, R.; Labandeira Guerra, C.; (PD) patients. Our aim was to analyze the effectiveness of safinamide on pain in PD patients from Cimas Hernando, M.I.; Cabo López, the SAFINONMOTOR (an open-label study of the effectiveness of SAFInamide on NON-MOTOR I.; Paz González, J.M.; Alonso Losada, symptoms in Parkinson´s disease patients) study.
    [Show full text]
  • Taste and Smell Disorders in Clinical Neurology
    TASTE AND SMELL DISORDERS IN CLINICAL NEUROLOGY OUTLINE A. Anatomy and Physiology of the Taste and Smell System B. Quantifying Chemosensory Disturbances C. Common Neurological and Medical Disorders causing Primary Smell Impairment with Secondary Loss of Food Flavors a. Post Traumatic Anosmia b. Medications (prescribed & over the counter) c. Alcohol Abuse d. Neurodegenerative Disorders e. Multiple Sclerosis f. Migraine g. Chronic Medical Disorders (liver and kidney disease, thyroid deficiency, Diabetes). D. Common Neurological and Medical Disorders Causing a Primary Taste disorder with usually Normal Olfactory Function. a. Medications (prescribed and over the counter), b. Toxins (smoking and Radiation Treatments) c. Chronic medical Disorders ( Liver and Kidney Disease, Hypothyroidism, GERD, Diabetes,) d. Neurological Disorders( Bell’s Palsy, Stroke, MS,) e. Intubation during an emergency or for general anesthesia. E. Abnormal Smells and Tastes (Dysosmia and Dysgeusia): Diagnosis and Treatment F. Morbidity of Smell and Taste Impairment. G. Treatment of Smell and Taste Impairment (Education, Counseling ,Changes in Food Preparation) H. Role of Smell Testing in the Diagnosis of Neurodegenerative Disorders 1 BACKGROUND Disorders of taste and smell play a very important role in many neurological conditions such as; head trauma, facial and trigeminal nerve impairment, and many neurodegenerative disorders such as Alzheimer’s, Parkinson Disorders, Lewy Body Disease and Frontal Temporal Dementia. Impaired smell and taste impairs quality of life such as loss of food enjoyment, weight loss or weight gain, decreased appetite and safety concerns such as inability to smell smoke, gas, spoiled food and one’s body odor. Dysosmia and Dysgeusia are very unpleasant disorders that often accompany smell and taste impairments.
    [Show full text]
  • Additional Antidepressant Pharmacotherapies According to A
    orders & is T D h e n r Werner and Coveñas, Brain Disord Ther 2016, 5:1 i a a p r y B Brain Disorders & Therapy DOI: 10.4172/2168-975X.1000203 ISSN: 2168-975X Review Article Open Access Additional Antidepressant Pharmacotherapies According to a Neural Network Felix-Martin Werner1, 2* and Rafael Coveñas2 1Higher Vocational School of Elderly Care and Occupational Therapy, Euro Academy, Pößneck, Germany 2Laboratory of Neuroanatomy of the Peptidergic Systems, Institute of Neurosciences of Castilla y León (INCYL), University of Salamanca, Salamanca, Spain Abstract Major depression, a frequent psychiatric disease, is associated with neurotransmitter alterations in the midbrain, hypothalamus and hippocampus. Deficiency of postsynaptic excitatory neurotransmitters such as dopamine, noradrenaline and serotonin and a surplus of presynaptic inhibitory neurotransmitters such as GABA and glutamate (mainly a postsynaptic excitatory and partly a presynaptic inhibitory neurotransmitter), can be found in the involved brain regions. However, neuropeptide alterations (galanin, neuropeptide Y, substance P) also play an important role in its pathogenesis. A neural network is described, including the alterations of neuroactive substances at specific subreceptors. Currently, major depression is treated with monoamine reuptake inhibitors. An additional therapeutic option could be the administration of antagonists of presynaptic inhibitory neurotransmitters or the administration of agonists/antagonists of neuropeptides. Keywords: Acetylcholine; Bupropion; Dopamine; GABA; Galanin; in major depression and to point out the coherence between single Glutamate; Hippocampus; Hhypothalamus; Major depression; neuroactive substances and their corresponding subreceptors. A Midbrain; Neural network; Neuropeptide Y; Noradrenaline; Serotonin; question should be answered, whether a multimodal pharmacotherapy Substance P with an agonistic or antagonistic effect at several subreceptors is higher than the current conventional antidepressant treatment.
    [Show full text]
  • Interface of Epilepsy and Sleep Disorders
    Seizure 1999; 8: 97 –102 View metadata, citation and similar papers at core.ac.uk brought to you by CORE Article No. seiz.1998.0257, available online at http://www.idealibrary.com on provided by Elsevier - Publisher Connector Interface of epilepsy and sleep disorders Roy G. Beran, Menai J. Plunkett & Gerard J. Holland St Lukes Hospital Telemetry and Sleep Centre, St Lukes Hospital, 18 Roslyn Street, Potts Point, NSW 2011, Australia Correspondence to: Dr Roy G. Beran, Suite 5, 6th Floor, 12 Thomas Street, Chatswood, NSW 2067, Australia Obstructive sleep apnoea was first brought to prominence by Henri Gastaut, a French epileptologist. Since that time the interface between epilepsy and sleep disorders has received less attention than might be justified, recognizing that sleep deprivation is a poignant provocateur for seizures. Sleep deprivation is often used as a diagnostic procedure during electroencephalography (EEG) when waking EEG has failed to demonstrate abnormality. Patients referred to an outpatient neurological clinic for evaluation of possible seizures in whom sleep disorder was suspected, either due to snoring during the EEG or based on history, were evaluated with all-night diagnostic polysomnography (PSG) and appropriate intervention administered as indicated. Patient and seizure demography, sleep disorder and response to therapy were reviewed and the interface explored. Fifty patients aged between 10 and 83 years underwent PSG. Approximately half were diagnosed with epilepsy and almost three-quarters had sleep disorders sufficiently intrusive to require therapy (either continuous positive air pressure (CPAP) or medication). With co-existence of epilepsy and sleep disorders, proper management of sleep disorders provided significant benefit for seizure control.
    [Show full text]
  • Epigenetic Pathways Through Which Experiences Become Linked with Biology
    Development and Psychopathology 27 (2015), 637–648 # Cambridge University Press 2015 doi:10.1017/S0954579415000206 Epigenetic pathways through which experiences become linked with biology a b PATRICK O. MCGowan AND TANIA L. ROTH aUniversity of Toronto; and bUniversity of Delaware Abstract This article highlights the defining principles, progress, and future directions in epigenetics research in relation to this Special Issue. Exciting studies in the fields of neuroscience, psychology, and psychiatry have provided new insights into the epigenetic factors (e.g., DNA methylation) that are responsive to environmental input and serve as biological pathways in behavioral development. Here we highlight the experimental evidence, mainly from animal models, that factors such as psychosocial stress and environmental adversity can become encoded within epigenetic factors with functional consequences for brain plasticity and behavior. We also highlight evidence that epigenetic marking of genes in one generation can have consequences for future generations (i.e., inherited), and work with humans linking epigenetics, cognitive dysfunction, and psychiatric disorder. Though epigenetics has offered more of a beginning than an answer to the centuries-old nature–nurture debate, continued research is certain to yield substantial information regarding biological determinants of central nervous system changes and behavior with relevance for the study of developmental psychopathology. Experiences, particularly those occurring during sensitive peri- To better understand the consequences of early and later- ods of development, are well recognized for their ability to ca- life stress on epigenetic mechanisms in this capacity, this nalize neurobiological trajectories and yield significant conse- has required the utilization of experimental rodent models quences for lifelong health and mental well-being.
    [Show full text]
  • Neurobiology and Behavior (NEURBIO) 1
    Neurobiology and Behavior (NEURBIO) 1 Neurobiology and Behavior (NEURBIO) Courses NEURBIO 200A. Research in Neurobiology and Behavior. 2-12 Units. Individual research with Neurobiology and Behavior faculty. Repeatability: Unlimited as topics vary. Restriction: Graduate students only. Neurobiology and Behavior Majors only. NEURBIO 200B. Research in Neurobiology and Behavior. 2-12 Units. Individual research with Neurobiology and Behavior faculty. Prerequisite: NEURBIO 200A Repeatability: Unlimited as topics vary. Restriction: Graduate students only. Neurobiology and Behavior Majors only. NEURBIO 200C. Research in Neurobiology and Behavior. 2-12 Units. Individual research with Neurobiology and Behavior faculty. Prerequisite: NEURBIO 200B Repeatability: Unlimited as topics vary. Restriction: Graduate students only. Neurobiology and Behavior Majors only. NEURBIO 201A. Research in Neurobiology and Behavior. 2-12 Units. Individual research with Neurobiology and Behavior faculty. Grading Option: Satisfactory/unsatisfactory only. Repeatability: Unlimited as topics vary. Restriction: Graduate students only. Neurobiology and Behavior Majors only. NEURBIO 201B. Research in Neurobiology and Behavior. 2-12 Units. Individual research with Neurobiology and Behavior faculty. Prerequisite: NEURBIO 201A Grading Option: Satisfactory/unsatisfactory only. Repeatability: Unlimited as topics vary. Restriction: Graduate students only. Neurobiology and Behavior Majors only. NEURBIO 201C. Research in Neurobiology and Behavior. 2-12 Units. Individual research with Neurobiology and Behavior faculty. Prerequisite: NEURBIO 201B Grading Option: Satisfactory/unsatisfactory only. Repeatability: Unlimited as topics vary. Restriction: Graduate students only. Neurobiology and Behavior Majors only. NEURBIO 202A. Foundations of Neuroscience. 2 Units. Intended to expose students to critical reading and analysis of the primary neuroscience literature. Instructors from departments associated with the Interdepartmental Neuroscience Program participate and discuss topics of current interest.
    [Show full text]
  • Effect of Nutrition on Neurodegenerative Diseases. a Systematic Review
    Nutritional Neuroscience An International Journal on Nutrition, Diet and Nervous System ISSN: 1028-415X (Print) 1476-8305 (Online) Journal homepage: https://www.tandfonline.com/loi/ynns20 Effect of nutrition on neurodegenerative diseases. A systematic review Vittorio Emanuele Bianchi, Pomares Fredy Herrera & Rizzi Laura To cite this article: Vittorio Emanuele Bianchi, Pomares Fredy Herrera & Rizzi Laura (2019): Effect of nutrition on neurodegenerative diseases. A systematic review, Nutritional Neuroscience, DOI: 10.1080/1028415X.2019.1681088 To link to this article: https://doi.org/10.1080/1028415X.2019.1681088 Published online: 04 Nov 2019. Submit your article to this journal Article views: 23 View related articles View Crossmark data Full Terms & Conditions of access and use can be found at https://www.tandfonline.com/action/journalInformation?journalCode=ynns20 NUTRITIONAL NEUROSCIENCE https://doi.org/10.1080/1028415X.2019.1681088 REVIEW Effect of nutrition on neurodegenerative diseases. A systematic review Vittorio Emanuele Bianchi a, Pomares Fredy Herrerab and Rizzi Laurac aEndocrinology and Metabolism, Clinical Center Stella Maris Falciano, Falciano, San Marino; bDirector del Centro de Telemedicina, Grupo de investigación en Atención Primaria en salud/Telesalud, Doctorado en Medicina /Neurociencias, University of Cartagena, Colombia; cMolecular Biology, School of Medicine and Surgery, University of Milano-Bicocca, Monza Brianza, Italy ABSTRACT KEYWORDS Neurodegenerative diseases are characterized by the progressive functional loss
    [Show full text]
  • Spinal Cord in Motor Neuron Diseases Using a Multi-Parametric MRI Approach
    Université Pierre et Marie Curie Cerveau Cognition Comportement Laboratoire d’Imagerie Biomédicale / Systèmes Dynamiques Anatomo-Fonctionnels chez l’Homme Thèse de Doctorat en Neurosciences Présentée par Mohamed-Mounir EL MENDILI Analysis of the structural integrity of the spinal cord in motor neuron diseases using a multi-parametric MRI approach Dirigée par Véronique MARCHAND-PAUVERT et Pierre-François PRADAT Présentée et soutenue le 13 Décembre 2016 devant le jury composé de Devant un jury composé de : M. Peter BEDE (PU-PH) Trinity College Dublin, Irland Rapporteur Mme. Virginie CALLOT (DR) Aix-Marseille Université Rapporteur M. Philippe CORCIA (PU-PH) Université François-Rabelais, Tours Examinateur M. Stéphane LEHERICY (PU-PH) Université Paris VI Examinateur Mme. Véronique MARCHAND-PAUVERT (DR) Université Paris VI Directeur de thèse M. Pierre-Francois PRADAT (PH) Université Paris VI Co-directeur de thèse This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License. À tous les patients atteints d’une des maladies du motoneurone Contents Contents ..................................................................................................................................... i Remerciements .................................................................................................................... iii List of Tables .......................................................................................................................... iv List of Figures ........................................................................................................................
    [Show full text]
  • Neuroscience Major Requirements (Fall 2017 Or Later)
    Neuroscience Major Requirements (Fall 2017 or later) Undergraduate Program in Neuroscience : 1140 Undergrad. Science Bldg. (USB) : http://www.lsa.umich.edu/neurosci : [email protected] : 734-763-7984 (front desk) Why study Neuroscience? Neuroscience is the study of the nervous system. Neuroscientists aim to understand how the nervous system develops and functions on a cellular level as well as the mechanisms that underlie behavior, mental disorders and disease. The faculty teaching courses in the major include cellular and molecular neuroscientists appointed in the Department of Molecular, Cellular and Developmental Biology (MCDB) and behavioral and cognitive neuroscientists appointed in the Department of Psychology. This interdisciplinary program gives students the best of both of these worlds. Who should major in Neuroscience? Any student who wishes to pursue a career studying the nervous system or behavior. This is an excellent major for anyone interested in pre-health careers, graduate studies, or careers in the biotech industry. Exclusions: Students who elect a major in Neuroscience may not elect the following majors: Biochemistry Biology Biology, Health & Society (BHS) Biomolecular Science (BMS) Biopsychology, Cognition and Neuroscience (BCN) Cellular & Molecular Biology (CMB) CMBS (formerly CMB:BME) Molecular, Cellular, and Developmental Biology (MCDB) Microbiology Plant Biology Students who elect a major in Neuroscience may not elect a minor in Biology, Plant Biology, Chemistry, or Biochemistry. Students can double major in Psychology and Neuroscience or Cognitive Science and Neuroscience, but may only share a maximum of 3 courses between their two programs. How do I declare? Students interested in neuroscience are encouraged to meet with an advisor to discuss their academic plans as soon as possible! Students need not have completed all of the prerequisites of the major to declare, but should usually have completed the biology introductory sequence with a 2.0 or better and be in good academic standing.
    [Show full text]
  • Lori Knackstedt
    Lori A. Knackstedt, PhD Psychology Department 114 Psychology Building P.O. Box 112250 Gainesville, FL 32611 Email: [email protected] Education Ph.D. 2005: Psychology; University of California, Santa Barbara, Santa Barbara, CA Advisor: Aaron Ettenberg Dissertation: “Motivating Factors Underlying the Co-administration of Cocaine and Alcohol” B.S. 1999: Bucknell University, Lewisburg, PA Major: Biology Magna cum laude Positions Held ______ 2012-present Assistant Professor Psychology Department University of Florida, Gainesville, FL 2008-2012 Research Assistant Professor Neurosciences Department Medical University of South Carolina, Charleston, SC 2005-2008 Post-doctoral Fellow Neurosciences Department Medical University of South Carolina, Charleston, SC Mentor: Peter Kalivas Teaching Experience 2010-2012 Lecturer: MUSC College of Medicine Lectured in the Neuroscience course component for 1rst year medical students and taught the 2 week neuroscience component of Gross Anatomy Lab 2005-2012 Adjunct Faculty: Psychology Dept., College of Charleston, Charleston, SC “PSYCH 103: Introduction to Psychological Science” “PSYCH 388: Psychology of Substance Abuse” “PSYCH 214: Behavioral Neuroscience” 2003-2004 Adjunct Faculty: Psych. Dept., Santa Barbara City College, Santa Barbara, CA “PSY 110: Intro to Physiological Psychology” C.V. Knackstedt 2 2003-2004 Instructor: University of California, Santa Barbara, Santa Barbara, CA “PSYCH 111: Concepts in Biological Psychology” “PSYCH 106: Brain and Behavior” Research Support Ongoing: NIDA: R01 DA033436 (PI:
    [Show full text]
  • A Systematic Review of Nutritional Risk Factors of Parkinson's Disease
    Nutrition Research Reviews (2005), 18, 259–282 DOI: 10.1079/NRR2005108 q The Authors 2005 A systematic review of nutritional risk factors of Parkinson’s disease Lianna Ishihara* and Carol Brayne Department of Public Health and Primary Care, University of Cambridge, Forvie Site, Robinson Way, Cambridge CB2 2SR, UK A wide variety of nutritional exposures have been proposed as possible risk factors for Parkinson’s disease (PD) with plausible biological hypotheses. Many studies have explored these hypotheses, but as yet no comprehensive systematic review of the literature has been available. MEDLINE, EMBASE, and WEB OF SCIENCE databases were searched for existing systematic reviews or meta-analyses of nutrition and PD, and one meta-analysis of coffee drinking and one meta-analysis of antioxidants were identified. The databases were searched for primary research articles, and articles without robust methodology were excluded by specified criteria. Seven cohort studies and thirty-three case–control (CC) studies are included in the present systematic review. The majority of studies did not find significant associations between nutritional factors and PD. Coffee drinking and alcohol intake were the only exposures with a relatively large number of studies, and meta-analyses of each supported inverse associations with PD. Factors that were reported by at least one CC study to have significantly increased consumption among cases compared with controls were: vegetables, lutein, xanthophylls, xanthins, carbohydrates, monosaccharides, junk food, refined sugar, lactose, animal fat, total fat, nuts and seeds, tea, Fe, and total energy. Factors consumed significantly less often among cases were: fish, egg, potatoes, bread, alcohol, coffee, tea, niacin, pantothenic acid, folate and pyridoxine.
    [Show full text]